Monitra Healthcare
Monitra Healthcare develops ambulatory cardiac monitoring devices and solutions, offering Holter monitors, external loop recorders, and mobile cardiac telemetry devices for continuous heart monitoring. The company provides diagnostic reporting services using proprietary tools and a review process to identify relevant cardiac events, delivering accurate tracings and annotations to assist physicians in diagnosing and…
Funding snapshot
About
Monitra Healthcare develops ambulatory cardiac monitoring devices and solutions, offering Holter monitors, external loop recorders, and mobile cardiac telemetry devices for continuous heart monitoring. The company provides diagnostic reporting services using proprietary tools and a review process to identify relevant cardiac events, delivering accurate tracings and annotations to assist physicians in diagnosing and treating heart conditions. Founded in 2016 and headquartered in Hyderabad, India, Monitra Healthcare has raised approximately $3.8M in Series A funding from investors including Sara Group, Haystack Investments, Equanimity Investments, Kotak Mahindra Bank, Indian Angel Network, BIRAC, ACG Group, and AWE Funds. The company focuses on improving diagnostic yield through redesigned clinical reporting workflows, addressing the growing demand for remote cardiac monitoring solutions in emerging markets where access to specialized cardiac care is limited.
Business model
Wearable Technology > Health and Wellness Devices > Cardiac,
Healthcare IT > Value Based Care > Remote Monitoring > Hardware > Cardiology > Wearable > ECG Patch,
Cardiac and Vascular Disorders > Medical Devices > Screening Devices > Cardiac Diagnostic > Electrodiagnostic Testing (ECG) > Home Based
Team background
College Wise > Carnegie Mellon University
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.